Salute e Benessere
Preclinical Imaging Market Worth $1,259 million | MarketsandMarkets™
Based on reagents, the preclinical imaging market is segmented into optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. Among these, optical imaging reagents segment accounted for the largest share of the preclinical imaging market in 2023. The large market share of the optical imaging reagents segment is attributed to the high penetration of optical imaging modalities in preclinical research studies
Based on application, the preclinical imaging market is segmented into oncology, cardiology, neurology, infectious diseases, immunology and inflammation, and other applications. In 2023, oncology segment accounted for the largest share of the market. This can be due to as oncology benefits greatly from advancements in molecular imaging, allowing researchers to target specific biomarkers associated with cancer cells. This provides valuable insights into tumour biology and drug targeting.
Based on end user, the preclinical imaging market is segmented into pharmaceutical & biotechnology companies, academic and research centers, imaging centers, and other end users. In 2023, the pharmaceutical & biotechnology companies segment accounted for the largest share in the market. The volume of research and development work conducted by these companies has increased significantly, accompanied by a rise in investment for these activities. The ongoing need for advanced drugs will continue to drive demand for research and development efforts. Biotechnology companies utilize this technology extensively due to its wide range of applications.
The preclinical imaging market is segmented into five major regional segments, namely, North America , Europe , Asia Pacific , Latin America and Middle East and Africa . North America is anticipated to dominate the preclinical imaging market due to its developed infrastructure, numerous preclinical projects, and higher adoption rates of advanced technological devices in the region.
1. Increasing market demand for non-invasive small animal imaging techniques
1. Strict regulations governing preclinical research
1. Increasing Adoption of Imaging Systems for Preclinical Purposes
1. Technological and procedural limitations associated with standalone preclinical imaging systems
Prominent players in the preclinical imaging market include MR Solutions (UK), Mediso Ltd. (UK), Sofie (US), Fujifilm Visual Sonics ( Canada ), MILABS B.V. ( Netherlands ), Aspect Imaging Limited (US), Li-Cor Biosciences (US), ICONEUS ( Paris ), Advanced Molecular Vision (UK), Viewworks (Korea), Kub Technologies (US), Medikor (US), Trifoil Imaging (US), IVIM Technology Corp. ( South Korea ), Cubresa, Inc. ( Canada ), Berthold Technologies GMBH & CO.KG ( Germany ), Miltenyi Biotech GmbH ( Germany ), AI4R ( France ), Bruker Corporation (US), and Revvity, Inc. (US).
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.
- Global Forecasts to 2029
- Global Forecasts to 2029
- Global Forecasts to 2028
- Global Forecasts to 2028
- Global Forecasts to 2027
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of , as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original content:https://www.prnewswire.co.uk/news-releases/preclinical-imaging-market-worth-1-259-million--marketsandmarkets-302155875.html